Clinical Trials Sponsored by Aerocrine AB

Total 1060 results

Moberg Pharma AB

Completed

Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

Distal Subungual Onychomycosis

Germany, United Kingdom, Poland
AB Biotics, SA

Completed

Interventional Study to Evaluate the Effect of the Oral Administration of L.Plantarum on Vaginal Microbiota

Vaginal Infection

Spain
Corline Biomedical AB

Completed

Renaparin® in Kidney Transplantation

Delayed Graft Function

Sweden
BioInvent International AB

Terminated

A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma

Multiple Myeloma

United States
Gedea Biotech AB

Completed

Clinical Performance of a Vaginal Pessary (pHyph) in Bacterial Vaginosis

Bacterial Vaginosis

Sweden
Sigrid Therapeutics AB

Completed

STAR Study Investigating Performance and Safety of the Medical Device SiPore15™

Overweight | PreDiabetes | Prediabetic State | Type2 Diabetes | Obese | Type2 Diabetes Mellitus | Pre Diabetes

Finland, Sweden
Cereno Scientific AB

Completed

Study Investigation Pharmacokinetics and Pharmacodynamics of CS1

Thrombosis

Sweden
Eurocine Vaccines AB

Completed

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU in Older Adults

Influenza

Sweden
Vivolux AB
Theradex

Terminated

Study of Safety and Tolerability of VLX600, an Iron Chelator, in Patients With Refractory Advanced Solid Tumors

Refractory Cancer

United States
Fertilitetscentrum AB
Vitrolife

Completed

Comparisons of Human Embryonic Development Using Single Medium With and Without the Addition of Antioxidants

Blastocyst | Human | Antioxidants | Culture Media | Embryo

Sweden
Eques Indolor AB

Completed

Patient Experience of Interventional Pain Management. Qualitative Study

Chronic Pain

Sweden
NordicInfu Care AB

Completed

NIMS- New Implantable Pump in Pulmonary Arterial Hypertension, a Safety Follow up

Pulmonary Hypertension Group 1 and 4 According to Nice Classification

Denmark, Norway, Sweden
Alligator Bioscience AB

Completed

ADC-1013 First-in-Human Study

Neoplasms | Solid Tumors

United Kingdom, Denmark, Sweden
Hansa Biopharma AB

Completed

Safety Study on IdeS in Healthy Volounteers

Healthy

Sweden
Isofol Medical AB

Completed

A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX (FORTO)

Osteosarcoma

Norway, Sweden, Hungary, Poland
DexTech Medical AB

Terminated

A Phase IIb Study to Evaluate Efficacy and Tolerability of ODX (Osteodex) in Metastatic CRPC

Prostate Cancer Metastatic

Sweden
Newron Sweden AB

Terminated

A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALS

Amyotrophic Lateral Sclerosis

Belgium, Netherlands
AnaMar AB
Covance

Completed

A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis

Atopic Dermatitis

United Kingdom
Active Biotech AB

Completed

Efficacy Study of ABR-215050 to Treat Prostate Cancer

Prostate Cancer

United States, Canada, Sweden
Active Biotech AB

Completed

A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer

Prostate Cancer

France, Poland, Ukraine, United Kingdom, United States, China, Germany, Taiwan, Spain, Belgium, Colombia, Israel, Bulgaria, India, Panama, Romania, Netherlands, Greece, Sweden, Korea, Republic of, Australia, Canada, Chile, New Zealand, ... and more
Calliditas Therapeutics AB

Completed

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease (NEFIGAN)

Primary IgA Nephropathy

Belgium, United Kingdom, Denmark, Finland, Sweden, Germany, Spain, Italy, Czech Republic, Netherlands
Active Biotech AB

Completed

An Open-Label Study to Evaluate Biomarkers and Safety in Systemic Sclerosis Patients Treated With ABR-215757 (Paquinimod)

Systemic Sclerosis

Germany, Sweden, Switzerland
Active Biotech AB

Completed

A Single Dose Metabolism and Mass Balance Study of 14C-ABR-215050 in Healthy Subjects

Healthy

Sweden
Swedish Match AB

Completed

Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette Smokers

Cigarette Smoking

United States
Oasmia Pharmaceutical AB

Completed

Study of Paclitaxel in Patients With Ovarian Cancer

Fallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal Cancer

Ukraine, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, Hungary, Latvia, Lithuania, Romania, Russian Federation, Serbia, Slovakia, Sweden
Moberg Pharma AB

Completed

A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis

Onychomycosis
BioInvent International AB

Completed

A Study of a Human Anti-Intercellular Adhesion Molecule-1 Monoclonal Antibody, in Patients With Multiple Myeloma

Multiple Myeloma

Denmark, Belgium, United States, Sweden
Karo Bio AB

Terminated

Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care (AKKA)

Heterozygous Familial Hypercholesterolaemia
Diamyd Therapeutics AB

Terminated

A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)

Type 1 Diabetes Mellitus

France, Germany, Finland, Italy, Netherlands, Slovenia, Spain, Sweden, United Kingdom
Verman Oy Ab

Unknown

Alpha-galactosidase Enzyme and Irritable Bowel Syndrome (ALFA)

Irritable Bowel Syndrome

Finland
Moberg Pharma AB

Completed

K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp

Seborrhoeic Eczema of the Scalp

Sweden
Resistentia Pharmaceuticals AB

Completed

Safety Study of Anti-IgE Immunotherapy in Allergic Patients

Allergy

New Zealand
Diamyd Therapeutics AB

Completed

Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes

Type 1 Diabetes

Sweden
LTB4 Sweden AB

Completed

A Pilot Study of LTB4 in HIV-1 Infected Adults

HIV Infections

Canada
Gesynta Pharma AB
CTC Clinical Trial Consultants AB; RISE Research Institutes of Sweden AB

Completed

A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248

Pharmacokinetic

Sweden
Yale University
Neurocrine Biosciences

Recruiting

Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults

Trichotillomania (Hair-Pulling Disorder)

United States
Yale University
Neurocrine Biosciences

Not yet recruiting

Reduction of Demoralization After Treatment of TD With Valbenazine

Tardive Dyskinesia
Neurocrine Biosciences
Voyager Therapeutics

Completed

Observational, Long-term Extension Study for Participants of Prior VY-AADC01 Studies

Parkinson's Disease

United States
Neurocrine Biosciences
Voyager Therapeutics

Active, not recruiting

VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

Parkinson's Disease

United States
Neurocrine Biosciences
Voyager Therapeutics

Completed

Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

Brain Diseases | Central Nervous System Diseases | Nervous System Diseases | Parkinson's Disease | Parkinsonian Disorders | Movement Disorders | Neurodegenerative Diseases | Idiopathic Parkinson's Disease | Basal Ganglia Disease

United States
Inhalation Sciences Sweden AB
CTC Clinical Trial Consultants AB; Pharm-Analyt Labor GmbH; PlantVision AB

Completed

Explorative Clinical Investigation to Investigate the Ability of PreciseInhale to Direct Regional Lung Targeting and Reduce the Degree of Throat Deposition and Subsequent Gastrointestinal Absorption in Healthy Volunteers After Inhalation of Test Drug Substances Via the PreciseInhale System

Nebulizers and Vaporizers

Sweden
University of Vermont
Neurocrine Biosciences

Recruiting

Evaluating a Telemedicine Neurological Consult Program for Drug-Induced Movement Disorders Using the RE-AIM Framework

Drug-Induced Movement Disorder

United States
Neurocrine Biosciences
Huntington Study Group

Active, not recruiting

Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease

Chorea, Huntington

United States, Canada
Neurocrine Biosciences
Huntington Study Group

Completed

Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease (KINECT-HD)

Chorea, Huntington

United States, Canada
WntResearch AB
Institut Català d'Oncologia; SMS-Oncology BV; SAGA diagnostics AB; Unilabs A/S; BioVica...

Active, not recruiting

Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer (NeoFox)

Colon Cancer

Spain
Spago Nanomedical AB
CTC Clinical Trial Consultants AB; Antaros Medical

Completed

A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer (SPAGOPIX-01)

Breast Cancer | Pancreas Cancer

Sweden
Molnlycke Health Care AB

Not yet recruiting

Evaluation of Adhesion Properties in Wound Care Devices

Adhesion Properties of Wound Care Devices

Sweden
Integrative Research Laboratories AB

Recruiting

A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)

Parkinson Disease

France, Poland, Spain, Germany, Sweden, Netherlands
Molnlycke Health Care AB

Recruiting

A Post-Market Clinical Investigation on Mepilex Border Post-Op (ARCTIS)

Surgical Wound

Belgium
Double Bond Pharmaceutical AB

Not yet recruiting

A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM (TARGLIO)

Newly Diagnosed Glioblastoma

Clinical Trials Sponsored by Aerocrine AB

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations